British Patient Capital approves £30m commitment

The UK government-backed investor has committed to a TMT-focused venture/growth capital fund.

Institution: British Patient Capital
Headquarters: Sheffield, UK
AUM: £7.3 billion ($9.1 billion; €8.55 billion)

British Patient Capital, a subsidiary of British Business Bank, has committed $30 million to Crane II, according to a press release from the firm.

Fund II, which is managed by Crane Venture Partners, has raised $140 million (£110 million; €129 million) to focus on software companies across Europe. Half the fund will invest into the UK and the remaining capital will be invested into other companies across Europe. The fund’s predecessor raised $90 million in 2019.

As shown below, British Patient Capital tends to focus its private equity commitments on venture capital and growth equity vehicles globally.

Platinum subscribers may click here for the investor’s full profile, including key contacts, allocation strategy and fund investments.